Product Information
ONDANSETRON 40 MG/20 ML VIAL is a generic product labeled by Accord Healthcare Inc., priced at $0.1644 per ML under NDC 16729029805. Its NADAC has been published 182 times since Nov 2, 2016.
FDA first approved this application on Jul 13, 2015. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Accord Healthcare Inc.NDC
16729029805
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
5/20/2026
Active Ingredients
ONDANSETRONApproval Type
Generic (ANDA)
FDA Application
ANDA206846FDA Approved
7/13/2015
TE Code
AP
On Market Since
10/20/2016
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON 40 MG/20 ML VIAL has been published 182 times since Nov 2, 2016, and over the history we have for it it has risen 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1644 per ML |
|---|---|
| All-time high | $0.3226 (Sep 15, 2021) |
| All-time low | $0.1153 (Nov 2, 2016) |
| 52-week high | $0.1726 |
| 52-week low | $0.1585 |
| Median price | $0.1755 |
| Average price | $0.2035 |
| Largest weekly change | +179.8% (Sep 23, 2020) |
| Weeks tracked | 182 |
| Tracking since | Nov 2, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
-0.8%
1Y
-2.1%
3Y
-49.0%
5Y
-49.0%
All
+42.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ondansetron market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Accord Healthcare Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON 40 MG/20 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON 40 MG/20 ML VIAL, manufactured by Accord Healthcare Inc., is $0.1644 per ML (NDC 16729029805), effective May 20, 2026.
How has the price of ONDANSETRON 40 MG/20 ML VIAL changed over time?
Over the history we have for it, the NADAC for ONDANSETRON 40 MG/20 ML VIAL has risen 42.6%. It has been tracked across 182 weekly CMS publications since Nov 2, 2016.
What are the highest and lowest recorded NADAC prices for ONDANSETRON 40 MG/20 ML VIAL?
Since Nov 2, 2016, the NADAC for ONDANSETRON 40 MG/20 ML VIAL has ranged from a low of $0.1153 (Nov 2, 2016) to a high of $0.3226 (Sep 15, 2021), with a median of $0.1755 per ML.
Are there cheaper alternatives to ONDANSETRON 40 MG/20 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of ONDANSETRON 40 MG/20 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONDANSETRON 40 MG/20 ML VIAL?
ONDANSETRON 40 MG/20 ML VIAL (NDC 16729029805) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.